Prevalence of hepatitis B virus and hepatitis C virus infection in patients with inflammatory bowel disease: a systematic review and meta-analysis

Giri, Suprabhat; Agrawal, Dhiraj; Afzalpurkar, Shivaraj; Kasturi, Sunil; Gopan, Amrit; Sundaram, Sridhar; Kale, Aditya

doi:10.5217/ir.2022.00094

Cited by 3 publications

(1 citation statement)

References 63 publications

(207 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The paper included 34 studies with a total of 17,022 IBD patients, and found that the prevalence of hepatitis B virus surface antigen in IBD patients was 3.3% and the prevalence of HCV antibody (anti-HCV) was 1.8%, which is not significantly different from the general population. [3] The use of corticosteroids and immunosuppressants in IBD patients may affect the course of HCV. A study by Loras showed that corticosteroids may lead to a large replication of HCV and potential liver damage.…”

Section: Discussionmentioning

confidence: 99%

Ulcerative colitis coexisting with hepatitis C: A rare occurrence

Liu,

Huan,

Wang

et al. 2023

Medicine

View full text Add to dashboard Cite

Introduction: We describe a rare case of a 54-year-old male diagnosed with both ulcerative colitis (UC) and hepatitis C virus (HCV), posing clinical challenges. Patient Concerns: The patient showed worsened UC symptoms, leading to further evaluations. Diagnosis: Dual diagnosis of UC and HCV was confirmed through endoscopy and serological tests, ruling out other hepatic causes. Interventions: Treatment involved methylprednisolone for UC and sofosbuvir/velpatasvir for HCV, with attention to drug interactions. Outcomes: Significant improvement was observed in both UC symptoms and HCV viral load post-treatment. Conclusion: This case underscores the need for nuanced treatment in managing concurrent UC and HCV, considering potential drug interactions and disease impacts.

show abstract

Section: Discussionmentioning

confidence: 99%

Ulcerative colitis coexisting with hepatitis C: A rare occurrence

Liu,

Huan,

Wang

et al. 2023

Medicine

View full text Add to dashboard Cite

show abstract

Protective role of flavonoids quercetin and silymarin in the viral-associated inflammatory bowel disease: an updated review

Zarenezhad

Abdulabbas

Kareem³

et al. 2023

Arch Microbiol

View full text Add to dashboard Cite

Infectious complications in patients with inflammatory bowel disease in Asia: the results of a multinational web-based survey in the 8th Asian Organization for Crohn’s and Colitis meeting

et al. 2023

View full text Add to dashboard Cite

Background/Aims: Infectious complications are major concerns when treating patients with inflammatory bowel disease (IBD). This study evaluated clinical differences across countries/regions in the management of infectious diseases in patients with IBD.Methods: A multinational online questionnaire survey was administered to participants at the 8th meeting of the Asian Organization for Crohn’s and Colitis. The questionnaire included questions regarding surveillance, diagnosis, management, and prevention of infection in patients with IBD.Results: A total of 384 physicians responded to the questionnaire. The majority of Korean (n = 70, 63.6%) and Chinese (n = 51, 51.5%) physicians preferred vancomycin to metronidazole in the treatment of <i>Clostridium difficile</i> infection, whereas more than half of the Japanese physicians (n = 62, 66.7%) preferred metronidazole. Physicians in Korea (n = 88, 80.0%) and China (n = 46, 46.5%) preferred a 3-month course of isoniazid and rifampin to treat latent tuberculosis infection, whereas most physicians in Japan (n = 71, 76.3%) favored a 9-month course of isoniazid. Most Korean physicians (n = 89, 80.9%) recommended hepatitis B virus (HBV) vaccination in patients lacking HBV surface antigen, whereas more than half of Japanese physicians (n = 53, 57.0%) did not consider vaccination.Conclusions: Differences in the diagnosis, prevention, and management of infections in patients with IBD across countries/regions reflect different prevalence rates of infectious diseases. This survey may broaden understanding of the real-world clinical settings across Asian countries/regions and provide information for establishing practical guidelines to manage patients with IBD.

show abstract

Prevalence of hepatitis B virus and hepatitis C virus infection in patients with inflammatory bowel disease: a systematic review and meta-analysis

Cited by 3 publications

References 63 publications

Ulcerative colitis coexisting with hepatitis C: A rare occurrence

Ulcerative colitis coexisting with hepatitis C: A rare occurrence

Protective role of flavonoids quercetin and silymarin in the viral-associated inflammatory bowel disease: an updated review

Infectious complications in patients with inflammatory bowel disease in Asia: the results of a multinational web-based survey in the 8th Asian Organization for Crohn’s and Colitis meeting

Contact Info

Product

Resources

About